MoonLake Immunotherapeutics Newsroom

MoonLake Analyst Ratings

BenzingaJul 1 06:42 ET

MoonLake Analyst Ratings

BenzingaJun 25 05:48 ET

MoonLake Analyst Ratings

BenzingaJun 10 13:48 ET

MoonLake Analyst Ratings

BenzingaMay 17 10:18 ET

Buy Rating Reaffirmed for MoonLake Immunotherapeutics Amidst Promising Clinical Trials and Strategic Development Plans

TipRanksMay 17 06:21 ET

MoonLake Immunotherapeutics Buy Rating Justified by Strong Clinical Execution and Financial Position

TipRanksMay 10 01:25 ET

HC Wainwright & Co. Reiterates Buy on MoonLake, Maintains $100 Price Target

BenzingaMay 8 15:17 ET

MoonLake Analyst Ratings

BenzingaMay 8 15:17 ET

MoonLake Immunotherapeutics Earns Buy Rating: Advancing Clinical Programs and Strong Financial Position

TipRanksMay 8 06:31 ET

MoonLake Analyst Ratings

BenzingaMay 8 05:54 ET

Analysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Rocket Pharmaceuticals (RCKT)

TipRanksMay 7 15:40 ET

MoonLake Immunotherapeutics' Sonelokimab Shows Promise in Psoriatic Arthritis and HS, Meriting a Buy Rating

TipRanksMay 2 11:50 ET

Strong Buy Rating for MoonLake Immunotherapeutics Based on Promising Sonelokimab Clinical Trials and Market Potential

TipRanksApr 26 15:00 ET

MoonLake Analyst Ratings

BenzingaApr 23 06:27 ET

Buy Rating Affirmed for MoonLake Immunotherapeutics Amid Promising Clinical Results for Sonelokimab

TipRanksApr 22 12:41 ET

MoonLake Analyst Ratings

BenzingaApr 11 07:27 ET

MoonLake Immunotherapeutics Buy Rating: Strategic Partnerships and Market Potential Fuel Optimism

TipRanksApr 11 06:30 ET

MoonLake Analyst Ratings

BenzingaApr 9 06:13 ET

MoonLake Analyst Ratings

BenzingaApr 2 07:07 ET

Analysts' Top Healthcare Picks: Argenx Se (ARGX), MoonLake Immunotherapeutics (MLTX)

TipRanksMar 15 00:25 ET